MarketInOut Stock Screener Log In | Sign Up
 

Cytek Biosciences Inc

NASDAQ • Healthcare • Medical Devices • Quote as of 05/05/2026 16:00
Cytek Biosciences Inc stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization596.64 mln
Float96.92 mln
Earnings Date05/07/2026

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-3.29
Reliable

Relative Strength

74 / 100
Outperforming

Debt / Equity

0.07
Debt-free

ROE

-17.76
Negative

Dividend Yield

0.00%
No dividend

Business Description

Founded in 1992 and headquartered in Fremont, California, Cytek Biosciences develops and sells instruments, software, and reagents that help scientists study cells in detail for biomedical research and clinical use. The company's product lineup includes a range of flow cytometers, imaging systems, and cell analyzers sold under the Cytek, Amnis, and Guava brands, along with supporting software and consumables. Cytek serves pharmaceutical companies, academic institutions, and contract research organizations, reaching customers through its own sales teams in North America, Europe, China, and the Asia-Pacific region, as well as through third-party distributors elsewhere in the world.

Key Fundamentals

EPS-0.52
ROE-17.76
RPS1.58
ROIC-19.98
ROA-13.68
EBITDA, mln-17.39
EV / EBITDA-19.29
EV / EBIT-11.43
Revenue, mln201
EV / Revenue1.67

Financial Strength

Altman Z-Score3.56
Piotroski F-Score 2 / 9
Beneish M-Score-3.29
Short Ratio12.98
Short % of Float7.95

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 4.6% 80 / 100   
1 Month 5.75% 59 / 100   
2 Months -7.72% 30 / 100   
6 Months 22.56% 83 / 100   
1 Year 23.83% 64 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us